WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment
With no drugs or vaccines yet approved for COVID-19 and the number of U.S. cases increasing by the thousands every ...
Tag: Clinical Trials
FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients
The FDA is facilitating access to convalescent plasma, antibody-rich blood products that are taken from blood donated by people who ...
Regeneron and Sanofi Begin Global Clinical Trial for Use of Sarilumab in Severe COVID-19 Patients
U.S. Phase 2/3 trial initiated and will begin enrolling patients immediately Regeneron is leading U.S. trials, Sanofi will lead upcoming ex-U.S. trials Regeneron Pharmaceuticals, ...
Patients in Nebraska Part of First COVID-19 Clinical Trial in U.S.
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed ...
China Launches Dozens of Clinical Trials to Identify Most Promising Treatments for COVID-19
A randomized, controlled trial is the gold standard of clinical research. But pulling one together for Covid-19 is complicated by ...
Ground Breaking Typhoid Vaccine Reduces Infections by 80 Percent in Nepal
A “ground breaking” typhoid vaccine has reduced cases of the bacterial disease by more than 80 percent in a trial ...
Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral
Atriva Therapeutics GmbH has announced the successful conclusion and top-line results of its Phase I clinical trial for its lead ...
Why Ebola Vaccine on Trial in DRC is Raising Hopes
The World Health Organisation (WHO) has emphasized that an experimental vaccine is playing a major role in controlling the spread ...
M2D2 Support and Seed Funding Available for Medical-Device Entrepreneurs
A joint partnership between UMass Lowell and UMass Medical School in Worcester, M2D2 is a business incubator that helps medical-device ...
Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium and the Critical Path Institute (C-Path) Predictive Safety Testing ...
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding
The National Institutes of Health (NIH) has selected Soligenix's SGX942 (dusquetide) for the treatment of oral mucositis in head and ...
First Human Trial of Live, Attenuated Zika Vaccine Begins
Vaccinations have begun in a first-in-human trial of an experimental Zika virus vaccine, the National Institute of Allergy and Infectious ...
MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments
Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat ...
Experimental MERS Antibody Therapeutics Enter Clinical Trial
Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat ...
USAMRIID Awards Select Agent Research Reagents Contract
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is the Department of Defense's (DoD) lead laboratory for medical ...
NIAID Virology Quality Assurance Program
The National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS (DAIDS) is seeking proposals from qualified offerors to ...
